Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Radioimmunoimaging of human lymphomas with I-131 tumor-specific monoclonal antibody

Conference · · J. Nucl. Med.; (United States)
OSTI ID:6844433
The purpose of this study was to radiolabel an IgG2a monoclonal antibody (Lym-1) and fragments (Fab and F(ab')2) directed against human lymphomas (Raji) and to determine the biodistribution and feasibility of radioimmunoimaging. Radiolabeling with I-131 was achieved using Iodogen to which the monoclonal antibody (MA) and NaI-131 were added. Radioimmunoreactivity was performed utilizing a live cell assay of lymphoma cells (Raji). Athymic nude mice, each bearing a right thigh human lymphoma (Raji), were injected with 150-300 ..mu..Ci of I-131 labeled Ma, including Fab and F(ab')2 fragments, imaged up to 7 days after injection, sacrificed, and organ biodistribution performed. Results of the study demonstrated significant loss of immunoreactivity with the radioiodinated Fab fragments (11% binding) as opposed to F(ab')2 fragments (61% binding) or the whole antibody (65% binding). Highest tumor uptake was observed for the whole I-131 labeled antibody (8.2%) followed by F(ab')2 fragments (4.4%) and Fab fragments (0.9%). The most rapid whole body excretion was observed for radioiodinated Fab fragments followed by F(ab')2 fragments and whole antibody. Optimum tumor visualization for the radioiodinated F(ab')2 fragments and whole antibody was observed at 3 and 7 days after injection, with tumor/whole body ratios of 0.65 and 0.60 for F(ab')2 fragments and whole antibody, respectively. Biodistribution data obtained 7 days after injection confirmed high tumor uptake and low soft tissue distribution with tumor/liver ratios of 20.3 and 30.1 for the radioiodinated whole antibody and F(ab')2 fragments, respectively.
Research Organization:
Northwestern Univ. Medical School, Chicago, IL
OSTI ID:
6844433
Report Number(s):
CONF-840619-
Conference Information:
Journal Name: J. Nucl. Med.; (United States) Journal Volume: 25:5
Country of Publication:
United States
Language:
English